ARX vs IMC

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

51MEDIUM

IMC

IMMURON FPO [IMC]

51MEDIUM

Score Breakdown

ARX IMC
Technical
29
69
Catalyst
53
50
Sentiment
50
50
Fundamental
78
64
Momentum
69
39
Risk Gate
47
45

Key Metrics

ARX Metric IMC
$201.1MMarket Cap$9.5M
60KAvg Volume (20d)245K
+0.1%Short InterestN/A
$0.80052-Week High$0.098
$0.35052-Week Low$0.027
-3.5%Daily Change+3.4%
$0.550Entry Price$0.030
-2.0%ROE-39.7%
-2.0%Profit Margin-62.1%

Active Signals

ARX Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Trading below both moving averages — the trend is working against this one
●Volume surging at 2.1x normal while price falls — heavy selling pressure
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (2.2x)
●Moderate revenue growth (+15%)

IMC Signals

●MACD just crossed bullish — momentum is shifting to the upside
●Above-average volume (1.9x) on a green day — buyers stepping up
●On a tear — up 11.1% over the last 5 days
●Beating the Small Ords index — relative strength of 1.16, so it's outpacing the pack
●Volatility is expanding fast — choppy price action, so buckle up
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (9 quarters)
●Low P/S ratio (1.3x)

Ask Scout AI to compare ARX and IMC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ARX Full Analysis → IMC Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).